Abstract
A better understanding of tumorigenesis is crucial for the development of specific molecular therapies that specifically target the neoplasm and reduce patient morbidity and mortality. PET measures a wide range of physiologic processes critical for understanding the pathophysiology of brain neoplasms with high sensitivity. Continuous developments in PET provide new insights into the diagnosis, classification, and pathophysiology of brain neoplasms. As such, PET has played an increasingly important role in the staging of brain neoplasms, image-guided therapy planning, and treatment monitoring. This article addresses the most commonly used agents in PET imaging of brain tumors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
